Target Company Overview: Amelis
Amelis, founded in 2002, is a leading provider in France for in-home assistance for the elderly and frail individuals. It offers customized support plans tailored to the specific needs of its clients, ensuring services are available 24/7. With a workforce of 1,800 caregivers and a network of 47 agencies, Amelis serves over 6,000 beneficiaries daily and has built a solid reputation since its establishment. Previously a subsidiary of Sodexo Home Care, the company was acquired by The Halifax Group in 2023, enjoying a steady growth trajectory.
The acquisition by Epiktet marks a significant step in the evolution of Amelis, aligning it with a robust parent company focused on providing essential services for vulnerable populations.
Industry Overview in France
The in-home care services industry in France is experiencing remarkable growth, driven by demographic changes and an increasing aging population. As the elderly demographic continues to rise, there is a pressing need for sustainable and effective home services, making this sector critically important in the current market landscape.
In France, the home care market is evolving to meet the demands of families seeking quality personal assistance for their aging members. This demand is complemented by government initiatives aimed at improving the quality of care and support available for senior citizens, which encourages investments in the sector.
Furthermore, the ongoing advancements in technology and data analytics are transforming service delivery in this industry. Companies that effectively utilize these technologies can improve operational efficiency and service quality, catering to the nuanced needs of their clients more effectively.
In this context, Epiktet's investment in Amelis is strategic, allowing the group to leverage its existing expertise in home services to enhance the overall quality and reach of in-home care for the elderly.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
The acquisition of Amelis is a pivotal move for the Epiktet group to diversify its portfolio, venturing into the rapidly expanding in-home care sector. This transaction aligns with Epiktet's strategic goal of addressing critical societal challenges, specifically the need for elderly care within home settings.
By integrating Amelis into its operations, Epiktet plans to enhance the synergy between its existing brands, such as Kinougarde and Complétude, fostering a holistic approach to family-related services that extend beyond child care and education into vital elderly assistance.
Investor Information: Epiktet Group
Founded in 1984, the Epiktet Group has established itself as a leader in the child care and home tutoring sectors in France under the brands Kinougarde and Complétude. With a focus on delivering quality services, the group has served more than 45,000 families, generating revenues exceeding €110 million.
Supported by RAISE Invest and GENEO Capital Entrepreneur since 2021, Epiktet is now poised to further expand its service portfolio and solidify its leadership position by diving into the in-home care market through this acquisition. This move reflects the group's commitment to broadening its impact in the service industry.
Dealert's View
This acquisition presents an exciting opportunity for Epiktet to make a significant impact in the in-home care sector, a market that promises growth and societal relevance. The synergies between Epiktet's existing services and Amelis's capabilities could lead to enhanced service offerings, benefiting both clients and caregivers.
The emphasis on quality support for both beneficiaries and employees is commendable, creating a positive work environment that may yield lower turnover rates and higher service satisfaction among clients. This aligns with the broader industry trend towards prioritizing both client and caregiver experiences.
Furthermore, with advancements in data utilization and technology integration, Epiktet is well-positioned to adopt innovative solutions that enhance efficiency and service delivery in the home care domain. The potential for growth through organic expansion and strategic acquisitions is significant.
Overall, this deal could be an exemplary case of how companies can innovate and adapt to societal needs while promoting sustainable growth. By effectively leveraging its existing strengths, Epiktet is likely to establish itself as a formidable player in the in-home assistance sector.
Similar Deals
ARCHIMED, Téthys Invest → Provepharm Life Solutions
2018
Cressey & Company LP → Paradigm Health
2025
Welsh, Carson, Anderson & Stowe → Constitution Surgery Alliance
2025
Salt Creek Capital → Real Diagnostics
2025
Groupe Epiktet
invested in
Amelis
in 2024
in a Strategic Partnership deal
Disclosed details
Revenue: $121M